Occupational asthma. Pharmacological treatment, prevention and specific immunotherapy?;Asthme professionnel: Quel traitement de fond, quelle prévention? Y a-t-il une place pour la désensibilisation?

Archives des Maladies Professionnelles et de Medecine du Travail

Volumn 63, Issue 8, 2002, Pages 638-643

  Pauli, G ^a   Gonzalez, M ^a   Bessot, J C ^a  

^a UNIVERSITY HOSPITAL OF STRASBOURG   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIGEN; BETA 2 ADRENERGIC RECEPTOR STIMULATING AGENT; CORTICOSTEROID; LATEX; VEGETABLE PROTEIN;

ALLERGY; FLOUR; HUMAN; IMMUNOTHERAPY; OCCUPATIONAL ASTHMA; PREVENTIVE MEDICINE; REVIEW; SENSITIZATION;

EID: 0141874150     PISSN: 12503274     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (24)

1. Pauli G., Kopferschmitt-Kubler M.C.: Pronostic médical. In: L'asthme professionnel, J.C. Bessot, G. Pauli; Margaux Orange Ed., Paris, 1999, 523-535.
2. Fabbri L.M., Daénieli D., Crescioli S., Bevilacqua P., Meli S., Saetta M., Mapp C.E.: Fatal asthma in a subject sensitized to toluene diisocyanate. Am. Rev. Respir. Dis., 1988, 137, 1494-1498.
3. Licitra C., Samo N., Ioli F.: Death due to asthma at workplace in a diphenylmethane diisocyanate. Respiration, 1997, 64, 111-113.
4. Kopferschmitt-Kubler M.C., Gassmann V., Blaumeiser M., Nisand G., Pauli G.: Outcomes of 55 cases of occupational asthma. Eur. Respir. J., 1995, 8 suppl., 301S.
5. Mapp C., Boschetto P., Dal Vecchio L. et al. Protective effects of antiasthma drugs in late asthmatic reactions and increased airway responsiveness induced by toluene di-isocyanate in sensitized subjects. Am. Rev. Respir. Dis., 1987, 136, 1403 Abst.
6. Di Franco A., Paggiaro P.L., Vagaggini B., Giannini S., Cianchetti S., Bartoli M.L., Bacci E., Bancalari L., Carletti A., Dente F.L., Giuntini C.: Treatment with inhaled steroids can improve airway inflammation in subjects with occupational asthma and persistent exposure. Eur. Respir. J., 1995, 8, suppl., 300S.
7. Sulotto F., Romano C., Piolatto G., Chiesa A., Giacco C.: Effects of long-term therapy with inhaled corticosteroids (beclomethasone dipropionate) in occupational asthma patients no longer exposed. Med. Lav., 1989, 80, 498-505.
8. Paggiaro P., Vagaggini B., Bacci E., Bancalari L., Carrara M., Di Franco A., Giannini D., Dente F.L., Giuntini C.: Prognosis of occupational asthma. Eur. Respir. J., 1994, 7, 761-767.
9. Maestrelli P., De Marzo N., Saetta M., Boscaro M., Fabbri L.M., Mapp C.: Effects of inhaled beclomethasone on airway responsiveness in occupational asthma. Am. Rev. Respir. Dis., 1993, 148, 407-412.
10. Malo J.C., Cartier A., Cote J., Milot J., Leblanc C., Paquette L., Ghezzo H., Boulet L.P.: Influence of inhaled steroids on recovery from occupational asthma after cessation of exposure: an XVII-month double-blind crossover study. Am. J. Respir. Crit. Care Med., 1996, 153, 953-960.
11. National asthma and prevention program. Guidelines for the diagnosis and management of asthma. Expert panel report 2. National Heart Lung and Blood Institute, NIH publication n° 97-4051, July 1997.
12. Gonzalez M., Cantineau A.: Prévention collective et individuelle. In: J.C. Bessot, G. Pauli. L'asthme professionnel. Margaux Orange Ed., 1999, Paris, pp. 537-548.
13. Abramson M., Puy R., Weiner J.: Immunotherapy in asthma: an updated systematic review. Allergy, 1999, 54, 1022-1041.
14. Wahn U., Siraganian R.P.: Efficacy of specificity of immunotherapy with laboratory animal allergen extracts. J. Allergy Clin. Immunol., 1980, 65, 413-421.
15. Taylor W., Ohman J., Lowell F.: Immunotherapy in cat induced asthma - Double blind trial with evaluation of bronchial responses to cat allergen and histamine. J. Allergy Clin. Immunol., 1978, 61, 283-287.
16. Ohman J., Findlay S., Leitermann K.: Immunotherapy in cat induced asthma. Double blind trial with evaluation of in vivo and-in vitro responses. J. Allergy Clin. Immunol., 1984, 74, 230-239.
17. Valovirta E., Koivikko A., Vanto T. et al.: Immunotherapy in allergy to dog: double blind clinical study. Ann. Allergy, 1984, 5, 85-88.
18. Van Metre T., Marsh D., Adkinson F. et al.: Immunotherapy for cat asthma. J. Allergy Clin. Immunol., 1988, 82, 1053-1058.
19. Varney V.A., Edwards J., Tabbah K. et al.: Clinical efficacy of specific immunotherapy to cat dander: a double blind placebo controlled trial. Clin. Exp. Allergy, 1997, 27, 860-867.
20. Wüthrich B.: Testergebnisse und Desensibilisierungsresultate bei den allergisch bedingten Bäckerkrankheiten. Praxis, 1968, 38, 1294-1303.
21. Armentia A., Martin-Santos J.M., Chintero A. et al. Baker's asthma: prevalence and evaluation of immunotherapy with a wheat flour extract. Ann. Allergy, 1990, 65, 265-272.
22. Pereira C., Rico P., Lourenço M., Lombardero M., Pinto-Mendes J., Chieira C.: Specific immunotherapy for occupational latex allergy. Allergy, 1999, 53, 287-296.
23. Leynadier F., Herman D., Vervloet D., André C.: Specific immunotherapy with a standardized latex extract versus placebo in allergic healthcare workers. J. Allergy Clin. Immunol., 2000, 106, 585-590.
24. Fearby S., Frew A.J.: Hunting the magic bullet in immunotherapy: new forms of old treatment or something completely different? Clin. Exp. Allergy, 2001, 31, 969-974.